SETDB1 and lung carcinoma: SETDB1 targeting in lung cancer has been attempted through the use of the methyltransferase inhibitor DZNep, which downregulates SETDB1 expression and H3K9me3 levels, decreasing lung cancer cell growth and increasing apoptosis [76].